Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name

๐ŸŽ $75,000 HOLIDAY MATCH IS LIVE๐ŸŽ

Make a gift during the season of giving!

EOY Giving 2025 Match Your Gift

HELP ๐Ÿ”“ $100,000 IN LIFESAVING SUPPORT ๐Ÿ’™

ONE DAY ONLY: Help ZERO raise $20,000

and unlock Harrity & Harrity's $80,000 match!

H4C EOY Giving Donate Now
ZERO Summit 2022 banner

Health Equity and Prostate Cancer

Reggie Tucker-Seely

Reggie Tucker-Seeley, Vice President of Health Equity at ZERO, and Dr. Joseph Osborne, Chief of Molecular Imaging and Therapeutics at New York-Presbyterian Hospital's Department of Radiology, explore cancer disparities, health equity, and the importance of equity in prostate cancer clinical trials.

This session was part of our VIRTUAL ZERO Prostate Cancer Summit, which took place from March 4 to 8, 2022.


Watch

Contributors

Reggie Tucker-Seeley, Vice President, Health Equity
Reggie Tucker-Seeley, Former Staff (VP, Health Equity)

Reggie was Vice President of Health Equity at ZERO Cancer from 2021-2023.

Dr. Joseph Osborne
Joseph Osborne, MD, PhD, Chief of Molecular Imaging & Therapeutics

Joseph Osborne M.D., Ph.D. is the Chief of Molecular Imaging and Therapeutics and a Professor of Radiology at Weill Cornell Medicine. He is an Attending Radiologist at New York-Presbyterian/Weill Cornell Medical Center.

Share